{"id":"CHEMBL100259","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"DRTQHJPVMGBUCF-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-20256","Uridine"],"crossReferences":{"PubChem":["26754144","8139953"],"Wikipedia":["Uridine"],"drugbank":["DB02745"],"chEBI":["16704"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL10413","canonicalSmiles":"O=C(O)Cn1c(=O)n(Cc2ccc(Br)cc2F)c(=O)c2ccc(Cl)cc21","inchiKey":"SXONDGSPUVNZLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZENARESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1014","FK-366","FR-74366","Zenarestat"],"crossReferences":{"PubChem":["144210777","170466650"],"drugbank":["DB02132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1067","canonicalSmiles":"NC(=O)N1c2ccccc2CC(O)c2ccccc21","inchiKey":"BMPDWHIDQYTSHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICARBAZEPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["10-hydroxy-carbamazepine","Licarbazepine"],"crossReferences":{"Wikipedia":["Eslicarbazepine_acetate","Licarbazepine"],"chEBI":["701"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1079087","canonicalSmiles":"COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\\C[C@@H](C)OC2=O","inchiKey":"NEQZWEXWOFPKOT-QHSZRYGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1079087","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL110","canonicalSmiles":"O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1","inchiKey":"CULUWZNBISUWAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZNIDAZOLE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benznidazole","NSC-299972","RO 07-1051","RO-07-1051","RO-7-1051"],"crossReferences":{"DailyMed":["benznidazole"],"PubChem":["124360168","170466539","56320744"],"Wikipedia":["Benznidazole"],"drugbank":["DB11989"]},"count":4,"approvedIndications":["DOID_10113","MONDO_0001444","EFO_0005044","EFO_0008559"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved indications."}
{"id":"CHEMBL1131","canonicalSmiles":"COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C","inchiKey":"IHUNBGSDBOWDMA-AQFIFDHZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ACITRETIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acitretin","Neotigason","Soriatane"],"synonyms":["Acitretin","Etretin","RO 10-1670","RO 10-1670/000","RO-101670000"],"crossReferences":{"DailyMed":["acitretin"],"PubChem":["144205565","26756475","29216416","49640651"],"Wikipedia":["Acitretin"],"drugbank":["DB00459"],"chEBI":["50173"]},"count":6,"approvedIndications":["EFO_1001494","EFO_0000676"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819","ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":6},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000756","EFO_0000764","EFO_0000249","MONDO_0002406","EFO_0000701","EFO_0000676","EFO_0000707"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for psoriasis vulgaris and psoriasis and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1161626","canonicalSmiles":"Cc1ccc(Nc2nccc(-c3ccnc(N4CCN(CCN)CC4)c3)n2)cc1Cl","inchiKey":"RHOOHUMOHVIXEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161681","canonicalSmiles":"O=NO","inchiKey":"IOVCWXUNBOPUCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NITROUS ACID","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nitrite (No2-)","Nitrous acid"],"crossReferences":{"DailyMed":["sodium%20nitrite"],"Wikipedia":["Nitrous_acid"],"drugbank":["DB09112"],"chEBI":["25567"]},"childChemblIds":["CHEMBL93268","CHEMBL3186418"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1164951","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"OCJWYBKRHNXUME-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMETHYLPHOSPHONIC ACID GUANOSYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200329","canonicalSmiles":"Cl.Clc1ccc2nsnc2c1NC1=NCCN1","inchiKey":"ZWUKMNZJRDGCTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIZANIDINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1079","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirdalud","Sirdalud mr","Tizanidine hydrochloride","Zanaflex"],"synonyms":["AN-021","AN021","DS 103-282","DS-103-282","Tizanidine hydrochloride"],"crossReferences":{"DailyMed":["tizanidine%20hydrochloride"],"PubChem":["56320475"]},"count":4,"approvedIndications":["HP_0001257"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["HP_0001257","MONDO_0002959","HP_0003419","HP_0006986","MONDO_0043510"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for spasticity and has 3 investigational indications."}
{"id":"CHEMBL1200446","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1.Cl","inchiKey":"FSSICIQKZGUEAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE HYDROCHLORIDE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pbz-sr","Tripelennamine hydrochloride"],"synonyms":["Tripelennamine chloride","Tripelennamine hydrochloride"],"crossReferences":{"PubChem":["26719674","56424144","855583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948."}
{"id":"CHEMBL1200492","canonicalSmiles":"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl","inchiKey":"DYCKFEBIOUQECE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NEFAZODONE HYDROCHLORIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL623","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dutonin","Nefazodone hydrochloride","Serzone"],"synonyms":["BMY 13754","BMY-13754","MJ 13,754-1","MJ-13754-1","Nefazodone hydrochloride"],"crossReferences":{"DailyMed":["nefazodone%20hydrochloride"],"PubChem":["144205288","144207123","170465078","26719737","49681554"],"chEBI":["7495"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200498","canonicalSmiles":"CS(=O)(=O)O.C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21","inchiKey":"CYETUYYEVKNSHZ-LGOOQLFJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALATROFLOXACIN MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201197","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":2006},"tradeNames":["Trovan preservative free"],"synonyms":["Alatrofloxacin","Alatrofloxacin mesylate","CP-116,517 -27","CP-116517-27"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in European Union and  United States initially in 2006 due to Hepatotoxicity."}
{"id":"CHEMBL1200500","canonicalSmiles":"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C","inchiKey":"KUVIULQEHSCUHY-XYWKZLDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLOMETHASONE DIPROPIONATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerobec 100","Aerobec 50","Aerobec fte 250","Asmabec clickhaler","Asmabec spacehaler","Beclazone 100","Beclazone 100 e-breathe","Beclazone 200","Beclazone 250","Beclazone 250 e-breathe","Beclazone 50","Beclazone 50 e-breathe","Becloaqua 50","Becloforte","Becloforte e-breathe","Becloforte integra","Becloforte-vm","Beclomet diprop","Beclomet hayfever","Beclomist","Beclotaide","Beclovent","Becodisks","Beconase","Beconase aq","Becotide","Becotide 100","Becotide 100 e-breathe","Becotide 200","Becotide 50","Becotide 50 e-breathe","Clenil modulite","Clipper","Filair 100","Filair 50","Filair fte","Fostair","Fostair nexthaler","Nasobec aq","Nasobec hayfever","Propaderm","Propaderm fte","Propaderm-a","Propaderm-c","Pulvinal beclomet","Qnasl","Qvar 100","Qvar 100 e-breathe","Qvar 40","Qvar 50","Qvar 50 e-breathe","Qvar 80","Qvar redihaler","Rino clenil","Vancenase","Vancenase aq","Vancenase pockethaler","Vanceril","Vanceril double strength","Ventide","Vivabec","Zonivent aquanasal"],"synonyms":["Beclometasone","Beclometasone dipropionate","Beclomethasone","Beclomethasone dipropionate","Beclomethasone dipropionate monohydrate","SCH 18020W","SCH 8020W","SCH-18020W","SGX-201","SGX-202","SGX-203"],"crossReferences":{"DailyMed":["beclomethasone%20dipropionate","beclomethasone%20dipropionate%20monohydrate"],"PubChem":["144206719","56463541"],"Wikipedia":["Beclometasone_dipropionate"],"drugbank":["DB00394"],"chEBI":["3002"]},"count":20,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","HP_0001742","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0013730","MONDO_0043579","EFO_0007486","EFO_0000768","EFO_1000702","EFO_1000644","HP_0001742","EFO_0004599","HP_0004798","EFO_0009715","HP_0002110","EFO_0004232","EFO_0007227","HP_0006536","Orphanet_70589","EFO_1000391","EFO_0000544","EFO_0000270","EFO_0000341","EFO_1001417","EFO_0003956"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL1200580","canonicalSmiles":"O=S([O-])CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)[O-])cc2)cc1.[Na+].[Na+]","inchiKey":"AZBNFLZFSZDPQF-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOXONE SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1570","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diasone sodium"],"synonyms":["Aldesulfone sodium","Sulfoxone sodium"],"crossReferences":{"Wikipedia":["Aldesulfone_sodium"]},"count":1,"approvedIndications":["EFO_0001054"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for leprosy."}
{"id":"CHEMBL1200635","canonicalSmiles":"CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl","inchiKey":"AKQNAIYKSALPKV-OYHXESGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTAMATE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201263","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnacort"],"synonyms":["Hydrocortamate chloride","Hydrocortamate hydrochloride"],"crossReferences":{"chEBI":["50854"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200666","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/[C@@H](O)C2CC2)C[C@@H](O)C[C@@H]1O","inchiKey":"LWQQLNNNIPYSNX-UROSTWAQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIPOTRIENE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcipotriene","Dovobet","Dovonex","Enstilar","Sorilux","Xamiol"],"synonyms":["Calcipotriene","Calcipotriene hydrate","Calcipotriol","MC 903","MC-903","PRI-2201"],"crossReferences":{"DailyMed":["calcipotriene","calcipotriene%20hydrate"],"PubChem":["144206022","170464710","49681738","50112719"],"drugbank":["DB02300"],"chEBI":["50749"]},"count":11,"approvedIndications":["EFO_1001494","EFO_0000676"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","HP_0000964","EFO_0000701","EFO_0000676","EFO_1001993","EFO_1001361","EFO_0004208","EFO_0000274","MONDO_0043771","EFO_0003894","EFO_0002496"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for psoriasis and psoriasis vulgaris and has 9 investigational indications."}
{"id":"CHEMBL1200732","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"ILKJAFIWWBXGDU-MOGDOJJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMCINONIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amcinonide","Cyclocort"],"synonyms":["Amcinonide","CL 34699","CL-34699"],"crossReferences":{"DailyMed":["amcinonide"],"PubChem":["144204964","56423154","855515"],"Wikipedia":["Amcinonide"],"drugbank":["DB00288"],"chEBI":["31199"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201271","canonicalSmiles":"CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1","inchiKey":"MOYGZHXDRJNJEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLIZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Buclizine"],"crossReferences":{"Wikipedia":["Buclizine"],"drugbank":["DB00354"],"chEBI":["3205"]},"childChemblIds":["CHEMBL2360580","CHEMBL1200403"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergy."}
{"id":"CHEMBL1201352","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1","inchiKey":"HTIKWNNIPGXLGM-YLINKJIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAPACURONIUM","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Respiratory toxicity"],"year":2001},"tradeNames":[],"synonyms":["Rapacuronium"],"crossReferences":{"Wikipedia":["Rapacuronium"],"drugbank":["DB04834"]},"childChemblIds":["CHEMBL1200549"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999. It was withdrawn in United States  in 2001 due to Respiratory toxicity."}
{"id":"CHEMBL1201477","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYESTRADIOL PHOSPHATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estradurin","Polyest phos"],"synonyms":["LEO 114","Polyestradiol phos phosphate","Polyestradiol phosphate"],"crossReferences":{"DrugCentral":["3482"],"Wikipedia":["Polyestradiol_phosphate"]},"count":1,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for neoplasm."}
{"id":"CHEMBL1201536","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE POLACRILEX","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Commit","Nicorette","Nicorette (mint)","Nicotine polacrilex","Thrive"],"synonyms":["Nicotine polacrilex"],"crossReferences":{"DailyMed":["nicotine%20polacrilex"]},"count":2,"approvedIndications":["EFO_0003768"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","MONDO_0002050","EFO_0003768","EFO_0004318"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for nicotine dependence and has 1 investigational indication."}
{"id":"CHEMBL1201607","drugType":"Antibody","blackBoxWarning":true,"name":"NATALIZUMAB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tysabri"],"synonyms":["AN100226M","ANTEGRAN","Natalizumab"],"crossReferences":{"DailyMed":["natalizumab"],"DrugCentral":["4970"],"Wikipedia":["Natalizumab"]},"count":13,"approvedIndications":["EFO_0003885","EFO_0000540","EFO_0000384"],"linkedTargets":{"rows":["ENSG00000115232"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000685","EFO_0000637","HP_0002140","EFO_0007323","EFO_0003929","EFO_0000540","EFO_0000384","EFO_0004599","EFO_0003885","EFO_0008520","EFO_0001378","EFO_0000692","EFO_0008522"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229914","canonicalSmiles":"Cc1cn([C@H]2CC[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"WVNRRNJFRREKAR-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229914","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229947","canonicalSmiles":"c1cn(CCCCCCn2ccnc2)cn1","inchiKey":"CHRPUSCNMSNSKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229947","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06968"]},"childChemblIds":["CHEMBL3140363","CHEMBL1923931"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230670","canonicalSmiles":"CCCCC/C=C\\C=C\\[C@@H](O)CCCCCCCC(=O)O","inchiKey":"NPDSHTNEKLQQIJ-UINYOVNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230670","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754872"],"drugbank":["DB07302"],"chEBI":["34496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231470","canonicalSmiles":"C=CC(C)(C)c1cc2cc3c(cc2oc1=O)O[C@H](C(C)(C)O)C3","inchiKey":"JCDLLLXYAICSQV-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHALEPIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chalepin"],"crossReferences":{"drugbank":["DB02205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231652","canonicalSmiles":"NOCC[C@H](N)C(=O)O","inchiKey":"FQPGMQABJNQLLF-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Canaline"],"crossReferences":{"Wikipedia":["Canaline"],"drugbank":["DB02821"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232258","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)O","inchiKey":"ROHFNLRQFUQHCH-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-LEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205602","170465492","26756690"],"drugbank":["DB01746"],"chEBI":["28225"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232511","canonicalSmiles":"CCOC(=O)NC","inchiKey":"SURZCVYFPAXNGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232511","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["74451"],"drugbank":["DB02856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233206","canonicalSmiles":"COc1cccc(-c2cccc([C@]3(C)CC(=O)N(C)C(N)=N3)c2)c1","inchiKey":"LQOCXPOKEPYGTJ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233206","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07874"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235440","canonicalSmiles":"O=C(O)[C@@H]1CSCN1","inchiKey":"DZLNHFMRPBPULJ-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Thiaproline"],"crossReferences":{"PubChem":["144205863","170466577","29217845"],"drugbank":["DB02846"],"chEBI":["45171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256287","canonicalSmiles":"COc1nc(C)nc(Cl)c1NC1=NCCN1.Cl","inchiKey":"ZZPAWQYZQVUVHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXONIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL19236","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moxonidine HCl"],"crossReferences":{"PubChem":["26753262","49681826","50106578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1269597","canonicalSmiles":"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"AQHMBDAHQGYLIU-XNFHFXFQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SCY 635","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCY-635","Scy 635"],"crossReferences":{"drugbank":["DB12451"]},"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL127516","canonicalSmiles":"CCCCOC(=O)c1ccc(N)cc1","inchiKey":"IUWVALYLNVXWKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAMBEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"," Psychiatric toxicity"],"year":1964},"tradeNames":["Butesin"],"synonyms":["Butamben","Butyl aminobenzoate"],"crossReferences":{"PubChem":["104171291","11112245","11532999","144203943","144207576","170465735","17389507"],"Wikipedia":["Butamben"],"drugbank":["DB11148"],"chEBI":["3231"]},"childChemblIds":["CHEMBL3142541"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1964 due to Dermatological toxicity and  Psychiatric toxicity."}
{"id":"CHEMBL1367605","canonicalSmiles":"CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1.Cl","inchiKey":"IDLSITKDRVDKRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITODRINE HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL83063","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ritodrine hydrochloride","Yutopar"],"synonyms":["Ritodrine hydrochloride"],"crossReferences":{"PubChem":["26748517","856010"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1374379","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1","inchiKey":"MAFMQEKGGFWBAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZONATATE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzonatate","Tessalon"],"synonyms":["Benzonatate"],"crossReferences":{"DailyMed":["benzonatate"],"DrugCentral":["326"],"PubChem":["11112254","144203949","170465391","56463355"],"drugbank":["DB00868"],"chEBI":["3032"]},"count":1,"approvedIndications":["HP_0012735"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958 and is indicated for cough. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1430611","canonicalSmiles":"CC(O)C(=O)O.COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC","inchiKey":"IIZVTUWSIKTFKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1430611","maximumClinicalTrialPhase":0,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11533042","56423144"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1455497","canonicalSmiles":"O=C(O)CC(O)C(=O)O","inchiKey":"BJEPYKJPYRNKOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Salivix"],"synonyms":["E-296","E296","FEMA NO. 2655","INS NO. 296","INS NO.296","INS-296","L-malic acid","Malic acid","Malic acid l-(-)-form","NSC-25941","NSC-9232"],"crossReferences":{"PubChem":["144208734","4243530"],"Wikipedia":["Malic_acid"],"drugbank":["DB12751"],"chEBI":["6650"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1500","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)CC[C@H]3[C@H]1C5","inchiKey":"IJVCSMSMFSCRME-KBQPJGBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydromorphine"],"crossReferences":{"PubChem":["144206439"],"Wikipedia":["Dihydromorphine"],"drugbank":["DB01565"],"chEBI":["4575"]},"childChemblIds":["CHEMBL543073"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1554","canonicalSmiles":"Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O","inchiKey":"RJURFGZVJUQBHK-IIXSONLDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DACTINOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cosmegen","Cosmegen lyovac","Dactinomycin"],"synonyms":["Actinomycin d","Dactinomycin","GNF-PF-2290","GNF-Pf-1977","NCI-C04682","NSC-3053"],"crossReferences":{"DailyMed":["dactinomycin"],"PubChem":["144205550","144209680","170464668","17390061","26755269","26755270"],"Wikipedia":["Actinomycin"],"drugbank":["DB00970"],"chEBI":["27666"]},"count":18,"approvedIndications":["EFO_0000616"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for neoplasm and has 17 investigational indications."}
{"id":"CHEMBL157729","canonicalSmiles":"Cc1ccc2nc[nH]c2c1","inchiKey":"RWXZXCZBMQPOBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Methylbenzimidazole","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Methylbenzimidazole"],"crossReferences":{"drugbank":["DB03177"],"chEBI":["40205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1590","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1","inchiKey":"KWGRBVOPPLSCSI-WCBMZHEXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pseudoephedrine","Pseudoephedrine polistirex"],"crossReferences":{"DailyMed":["pseudoephedrine%20hydrochloride","pseudoephedrine%20sulfate"],"PubChem":["11111142"],"Wikipedia":["Pseudoephedrine"],"drugbank":["DB00852"],"chEBI":["51209"]},"childChemblIds":["CHEMBL1200724","CHEMBL1201483","CHEMBL3989855"],"count":12,"approvedIndications":["HP_0001742"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","EFO_0007486","HP_0012735","MONDO_0024290","EFO_0003821","EFO_0005252","EFO_0007533","MONDO_0024352","HP_0001742","EFO_0003843","EFO_0007214","MONDO_0024355","EFO_1001050","MP_0001845","EFO_0000544","EFO_0007328","MONDO_0003276","EFO_1001417","EFO_0003956","EFO_0003785"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for nasal obstruction and has 11 investigational indications."}
{"id":"CHEMBL1597075","canonicalSmiles":"CC1CCC(C(C)C)C(OC(=O)c2ccccc2N)C1","inchiKey":"SOXAGEOHPCXXIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERADIMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Menthyl anthranilate","Meradimate"],"crossReferences":{"PubChem":["144205155","144207759","29215280"],"drugbank":["DB11096"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1616433","canonicalSmiles":"CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C","inchiKey":"NPGNOVNWUSPMDP-HLLBOEOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1616433","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01605"],"chEBI":["51210"]},"childChemblIds":["CHEMBL1355196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1617","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"NZCRJKRKKOLAOJ-XRCRFVBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAXIMIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Normix","Rifacol","Targaxan","Xifaxan","Xifaxanta"],"synonyms":["Rifaxidin","Rifaximin"],"crossReferences":{"DailyMed":["rifaximin"],"PubChem":["144205082"],"Wikipedia":["Rifaximin"],"drugbank":["DB01220"],"chEBI":["75246"]},"count":28,"approvedIndications":["EFO_0000544","HP_0002014"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for infection and diarrhea and has 26 investigational indications."}
{"id":"CHEMBL1648","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12","inchiKey":"HMJIYCCIJYRONP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISRADIPINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynacirc","Dynacirc cr","Isradipine","Prescal"],"synonyms":["Isradipine","Isrodipine","PN 200-110","PN-200-110"],"crossReferences":{"DailyMed":["isradipine"],"PubChem":["144204241","170465070"],"Wikipedia":["Isradipine"],"drugbank":["DB00270"]},"count":8,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0004319","EFO_0000289","EFO_0003890","EFO_0002508","EFO_0003768","EFO_0000319","EFO_0005611","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for cardiovascular disease and has 7 investigational indications."}
{"id":"CHEMBL167911","canonicalSmiles":"COP(=O)(OC)OC=C(Cl)Cl","inchiKey":"OEBRKCOSUFCWJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORVOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atgard","Equigard","Equigel","Task tabs"],"synonyms":["DDVP","Dichlorvos","SD 1750"],"crossReferences":{"PubChem":["144204603","144208815","144211157","170466226","17389058","17389925","26752865","26752866"],"Wikipedia":["Dichlorvos"],"drugbank":["DB11397"],"chEBI":["34690"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743023","drugType":"Antibody","blackBoxWarning":false,"name":"FULRANUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 403","AMG-403","AMG403","Fulranumab","JNJ 42160443","JNJ-42160443"],"count":5,"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0002506","HP_0012532","HP_0003419","EFO_0003843"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743051","drugType":"Antibody","blackBoxWarning":false,"name":"ONARTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["METMA-B","Metmab","Onartuzumab","PRO-143966","PRO-143996","PRO143966","RO-5490258","RO5490258"],"count":9,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","MONDO_0008903","EFO_0000182","MONDO_0007254","EFO_0003060","EFO_0000519","EFO_0000311","EFO_1001951"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1743069","drugType":"Antibody","blackBoxWarning":false,"name":"SIFALIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1103","MEDI-545","Sifalimumab"],"count":3,"linkedTargets":{"rows":["ENSG00000147885","ENSG00000233816","ENSG00000197919","ENSG00000137080","ENSG00000214042","ENSG00000120242","ENSG00000236637","ENSG00000186803","ENSG00000234829","ENSG00000120235","ENSG00000188379","ENSG00000147873","ENSG00000228083"],"count":13},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000398","MONDO_0004670","EFO_0000676"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743087","drugType":"Antibody","blackBoxWarning":false,"name":"VEDOLIZUMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entyvio"],"synonyms":["LDP-02","LDP02","MLN-0002","MLN-02","MLN0002","MLN02","Vedolizumab"],"crossReferences":{"DailyMed":["vedolizumab"],"DrugCentral":["4982"]},"count":9,"approvedIndications":["EFO_0000729","EFO_0000540","EFO_0000384"],"linkedTargets":{"rows":["ENSG00000115232","ENSG00000139626"],"count":2},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000729","EFO_0000544","EFO_0000756","EFO_0000764","EFO_0000180","EFO_0000540","EFO_0000384","EFO_0003767"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL1743323","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1)[C@H]2O5","inchiKey":"YOYLLRBMGQRFTN-IOMBULRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORBUPRENORPHINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norbuprenorphine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1788396","canonicalSmiles":"O=[As](O)(O)c1ccc(NCCNc2ccc([As](=O)(O)O)cc2)cc1","inchiKey":"YQVALJGIKVYRNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFETARSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Difetarsone","Diphetarsone","RP 4763 [AS SODIUM SALT)"],"crossReferences":{"drugbank":["DB13599"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180300","canonicalSmiles":"C[C@@H](COc1ccc([C@@H]2Oc3ccc(O)cc3S[C@@H]2c2ccc(O)cc2)cc1)N1CCCC1","inchiKey":"UZOOIPXOYYJULJ-RHLLTPQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180300","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02715"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1874590","canonicalSmiles":"CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"KRRAUGJKMHOFMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1874590","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206083","170465607","49681544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19","canonicalSmiles":"CC(=O)/N=c1/sc(S(N)(=O)=O)nn1C","inchiKey":"FLOSMHQXBMRNHR-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAZOLAMIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methazolamide","Neptazane"],"synonyms":["L-584601","Methazolamide","VVP-808","VVP808"],"crossReferences":{"DailyMed":["methazolamide"],"PubChem":["11112413","56422398","855821"],"Wikipedia":["Methazolamide"],"chEBI":["6822"]},"count":3,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000167434","ENSG00000168748","ENSG00000133742","ENSG00000104267"],"count":4},"linkedDiseases":{"rows":["EFO_0009444","MONDO_0002974","EFO_1000782","EFO_0000516"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for glaucoma and has 2 investigational indications."}
{"id":"CHEMBL1908351","canonicalSmiles":"Cc1cnc(NCCCN(C)C)c2c1[nH]c1ccc3cc(O)ccc3c12","inchiKey":"QROONAIPJKQFMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INTOPLICINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Intoplicine","RP 60475","RP-60475 FREE BASE"],"crossReferences":{"drugbank":["DB12868"]},"childChemblIds":["CHEMBL1972308"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL193240","canonicalSmiles":"O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1","inchiKey":"MNDBXUUTURYVHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROFLUMILAST","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daliresp","Daxas"],"synonyms":["B-9302-107","B9302-107","BY-217","BY217","BYK-20869","BYK20869","Roflumilast"],"crossReferences":{"DailyMed":["roflumilast"],"PubChem":["165222658","174007051"],"Wikipedia":["Roflumilast"],"drugbank":["DB01656"],"chEBI":["47657"]},"count":15,"approvedIndications":["HP_0006536","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["Orphanet_797","EFO_0003095","HP_0000726","EFO_0000464","EFO_0000618","EFO_0000274","MONDO_0004784","EFO_0001073","EFO_0000311","HP_0002110","HP_0100543","HP_0006536","EFO_0000270","EFO_0006505","MONDO_0002406","EFO_0000676","EFO_0000574","EFO_0000341","EFO_0001360","EFO_0000692"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for airway obstruction and chronic obstructive pulmonary disease and has 13 investigational indications."}
{"id":"CHEMBL19980","canonicalSmiles":"C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1","inchiKey":"KQNZDYYTLMIZCT-KQPMLPITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BREFELDIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["105751","26751525","396903","56422115","56463468"],"Wikipedia":["Brefeldin_A"],"drugbank":["DB07348"],"chEBI":["48080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028663","canonicalSmiles":"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1","inchiKey":"BFSMGDJOXZAERB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABRAFENIB","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tafinlar"],"synonyms":["Dabrafenib","GSK-2118436","GSK-2118436A","GSK2118436A","Gsk2118436"],"crossReferences":{"DailyMed":["dabrafenib%20mesylate"],"drugbank":["DB08912"],"chEBI":["75045"]},"childChemblIds":["CHEMBL2105729"],"count":18,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","MONDO_0002108","EFO_0000756","EFO_1000926","EFO_1001968","EFO_0003060","EFO_0000311","MONDO_0015917","EFO_1001480","EFO_0002892","EFO_0000389","MONDO_0008903","EFO_0001421","EFO_0000501","EFO_0000641","EFO_0001378","EFO_0003833","MONDO_0021637","EFO_0002617","MONDO_0017795"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for neoplasm and cancer and has 16 investigational indications."}
{"id":"CHEMBL2037002","canonicalSmiles":"O=[N+]([O-])c1nccn1CC(O)C[18F]","inchiKey":"HIIJZYSUEJYLMX-JZRMKITLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[18F]FLUOROMISONIDAZOLE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2068841","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[18F]-Fluoromisonidazole","[18f]fluoromisonidazole"],"crossReferences":{"drugbank":["DB14830"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL204021","canonicalSmiles":"CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2","inchiKey":"WDPFJWLDPVQCAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARAPLADIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darapladib","SB-480848"],"crossReferences":{"drugbank":["DB06311"]},"childChemblIds":["CHEMBL3793364"],"count":3,"linkedTargets":{"rows":["ENSG00000146070"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0003770","EFO_1001461","EFO_0005672"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2052012","canonicalSmiles":"[3H]c1nc2c([3H])c(Cl)c([3H])c([3H])c2c(N([3H])C([3H])(C([3H])([3H])[3H])C([3H])([3H])C([3H])([3H])C([3H])([3H])N(C([3H])([3H])C([3H])([3H])[3H])C([3H])([3H])C([3H])([3H])[3H])c1[3H]","inchiKey":"WHTVZRBIWZFKQO-BYSMFQJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]-CHLOROQUINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chloroquine [3H]"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096895","canonicalSmiles":"Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1","inchiKey":"GWNHAOBXDGOXRR-HJFSHJIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADEFOVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradefovir"],"crossReferences":{"drugbank":["DB15550"]},"childChemblIds":["CHEMBL3989658"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2103772","canonicalSmiles":"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1","inchiKey":"ODUOJXZPIYUATO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACECADOTRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hidrasec"],"synonyms":["Racecadotril"],"crossReferences":{"PubChem":["174006909"],"drugbank":["DB11696"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103834","canonicalSmiles":"CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC","inchiKey":"KCJJINQANFZSAM-HZDSEHBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYLVALOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aivlosin"],"synonyms":["Tylvalosin"],"crossReferences":{"drugbank":["DB11554"]},"childChemblIds":["CHEMBL2105658"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103873","canonicalSmiles":"CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","inchiKey":"JGCMEBMXRHSZKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MACITENTAN","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Opsumit"],"synonyms":["ACT 064992","ACT-064992","Macitentan"],"crossReferences":{"DailyMed":["macitentan"],"drugbank":["DB08932"],"chEBI":["76607"]},"count":10,"approvedIndications":["Orphanet_422","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","EFO_0009197","EFO_0000768","EFO_0003144","Orphanet_422","EFO_0005207","MONDO_0043839","EFO_0000717","EFO_0000519","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for idiopathic and/or familial pulmonary arterial hypertension and hypertension and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105060","canonicalSmiles":"CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1","inchiKey":"MYCMTMIGRXJNSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXAVERINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moxaverine"],"crossReferences":{"PubChem":["170466298"],"drugbank":["DB12251"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105158","canonicalSmiles":"COc1cc(C(=O)c2ccc(Cl)cc2)cc(OC)c1OCCN1CCOCC1","inchiKey":"KVCJCEKJKGLBOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORCLOFONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morclofone"],"crossReferences":{"drugbank":["DB13558"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105552","canonicalSmiles":"C=CC1(C(C)CCC)C(=O)NC(=O)NC1=O","inchiKey":"KGKJZEKQJQQOTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYLBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyvinyl","JD-96","Vinylbital","Vinymal"],"crossReferences":{"drugbank":["DB13770"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105682","canonicalSmiles":"CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"ZLFZITWZOYXXAW-QXXZOGQOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EDOXABAN TOSYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1269025","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Savaysa"],"synonyms":["DU-176B","Edoxaban tosilate","Edoxaban tosylate"],"crossReferences":{"DailyMed":["edoxaban%20tosylate"],"chEBI":["85975"]},"count":6,"approvedIndications":["EFO_0000275","EFO_0003827","EFO_0000712","EFO_0003907"],"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","MONDO_0000831","EFO_0003827","EFO_0000712","EFO_0004286","EFO_0003907"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105698","canonicalSmiles":"CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1.Cl","inchiKey":"LGMSNQNWOCSPIK-LWHGMNCYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVOCIDIB HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL428690","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvocidib hydrochloride","Flavopiridol hydrochloride","HL 275","HMR 1275","L 86 8275","L-86-8275","MDL-107826A"],"crossReferences":{"PubChem":["144206947","170466414"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2105735","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1","inchiKey":"XRWSZZJLZRKHHD-WVWIJVSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASUNAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asunaprevir","BMS 650032","BMS-650032"],"crossReferences":{"drugbank":["DB11586"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106003","canonicalSmiles":"CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1.O=C(O)/C=C\\C(=O)O","inchiKey":"QIQWRCNAPQJQLL-COALEZEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPRALISANT MALEATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL278462","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Perceptin"],"synonyms":["Cipralisant maleate","GT-2331","Gt2331"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107430","canonicalSmiles":"Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1","inchiKey":"QHMWCHQXCUNUAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTRIMAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Micetal"],"synonyms":["Flutrimazole","UR-4056"],"crossReferences":{"drugbank":["DB13425"],"chEBI":["82864"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107757","canonicalSmiles":"N#CCC/C(O)=C(\\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1","inchiKey":"OQUXVPJVBSENGK-QXMHVHEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANITIMUS","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FK-778","FK778","Fk778","HMR 1715","HMR-1715","MNA-715","Manitimus"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108047","drugType":"Unknown","blackBoxWarning":false,"name":"RINFABATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RHIGFBP-3","Rinfabate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108505","drugType":"Enzyme","blackBoxWarning":false,"name":"LACTASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-galactosidase (aspergillus)","G9S0VV191I","Lactase"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108585","drugType":"Gene","blackBoxWarning":false,"name":"CONTUSUGENE LADENOVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Advexin"],"synonyms":["AD5CMV-P53","Contusugene ladenovec","INGN 201"],"count":9,"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2108712","drugType":"Small molecule","blackBoxWarning":false,"name":"PLOVAMER ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CO-14","PI-2301","Plovamer acetate"],"count":1,"linkedTargets":{"rows":["ENSG00000196126"],"count":1},"linkedDiseases":{"rows":["EFO_0003929"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109000","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOXYMETHYLCELLULOSE CALCIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carboxymethylcellulose calcium","Carmellose","Carmellose calcium"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109263","drugType":"Antibody","blackBoxWarning":false,"name":"ING-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HEMAB","ING-1","Ing-1"],"count":1,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000228"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109417","drugType":"Antibody","blackBoxWarning":false,"name":"EMD-273063","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APN301","EMD 273063","EMD-273063","Emd-273063","HU14.18-IL2","Hu14.18-il2","Lorukafusp alfa"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109421","drugType":"Antibody","blackBoxWarning":false,"name":"4B5","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4B5","4b5"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109568","drugType":"Antibody","blackBoxWarning":false,"name":"HNK20","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HNK20"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109600","drugType":"Antibody","blackBoxWarning":false,"name":"RO-5458640","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7212","RO-5458640","Ro-5458640"],"count":1,"linkedTargets":{"rows":["ENSG00000239697"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109629","drugType":"Antibody","blackBoxWarning":false,"name":"ANETUMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anetumab ravtansine","BAY 94-9343","BAY-94-9343","BAY-949343","BAY94-9343"],"count":8,"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1000044","EFO_0003893","EFO_0000588","MONDO_0021117","EFO_0000770","EFO_0003060","EFO_0000311"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2110814","canonicalSmiles":"CNCCC(c1cccc(F)c1)c1cccc(F)c1","inchiKey":"MUGNLPWYHGOJEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELUCEMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Delucemine"],"childChemblIds":["CHEMBL2106165"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2111110","canonicalSmiles":"C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1","inchiKey":"CTIRHWCPXYGDGF-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDISAMIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KC8857","Tedisamil"],"childChemblIds":["CHEMBL2107378"],"count":1,"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000129159","ENSG00000168263","ENSG00000053918","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000135519","ENSG00000158445","ENSG00000177301","ENSG00000168418","ENSG00000089558","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2111157","canonicalSmiles":"CCC(=O)C(CC(C)N1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"SVDHSZFEQYXRDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPIPANONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dipipanone"],"crossReferences":{"drugbank":["DB01491"]},"childChemblIds":["CHEMBL2107606"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2178575","canonicalSmiles":"COc1cccc2c1c(NS(=O)(=O)c1ccc(Cl)s1)nn2Cc1cccc(NC(=O)CO)c1","inchiKey":"JVBQEIRQUCWMTR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2239633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK 2239633A","GSK2239633","Gsk-2239633"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2206196","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O","inchiKey":"LJRDOKAZOAKLDU-UDXJMMFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAROMOMYCIN SULFATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL370143","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabbroral","Humatin","Paromomycin sulfate"],"synonyms":["Aminosidine sulfate","Crestomycin sulfate","Estomycin sulfate","Paromomycin sulfate"],"crossReferences":{"DailyMed":["paromomycin%20sulfate"],"PubChem":["144205902"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 3 investigational indications."}
{"id":"CHEMBL220896","canonicalSmiles":"Nc1ncccc1NCc1cccc(-c2ccc3cc[nH]c3c2)c1","inchiKey":"LPQUIIHPUGDHJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218872","canonicalSmiles":"CC(=O)O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O","inchiKey":"KBIZSMHYSQUHDH-BBPGQOGGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VAPREOTIDE ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103975","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Docrised (mexico)","Octastatin","Sanvar"],"synonyms":["BMY-41606","DP-05-094","RC-160","Vapreotide acetate"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231813","canonicalSmiles":"CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1","inchiKey":"BBAWEDCPNXPBQM-GDEBMMAJSA-N","drugType":"Protein","blackBoxWarning":true,"name":"TELAPREVIR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Incivek","Incivo"],"synonyms":["LY 570310","LY-570310","MP 424","MP-424","Telaprevir","VRT 111950","VRT-111950","VX 950","VX-950"],"crossReferences":{"Wikipedia":["Telaprevir"],"drugbank":["DB05521"],"chEBI":["68595"]},"childChemblIds":["CHEMBL573043"],"count":7,"approvedIndications":["EFO_0000763"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for viral disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2356712","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1.Cl","inchiKey":"XEMPUKIZUCIZEY-YSCHMLPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2356712","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103761","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206561"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2358534","canonicalSmiles":"Cl.c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"ZUCZFANFKYSVKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2358534","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1396","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206454","170465218"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364626","canonicalSmiles":"CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21","inchiKey":"XPPBBJCBDOEXDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALIMETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSN-2322600 FREE BASE","LSN2322600 FREE BASE","LY-2228820","LY2228820","LY22288220","Ly-2228820","Ralimetinib"],"crossReferences":{"drugbank":["DB11787"]},"childChemblIds":["CHEMBL2364627"],"count":5,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0015686","MONDO_0008170","MONDO_0007254","EFO_0000519","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL23832","canonicalSmiles":"O=C(O)c1ccccc1Nc1ccccc1","inchiKey":"ZWJINEZUASEZBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENAMIC ACID ","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Phenylamino)Benzoic Acid","2-Phenylamino-Benzoic Acid","Fenamic acid ","N-Phenylanthranilic Acid"],"crossReferences":{"PubChem":["11110659","124878982","124878985","26747414","26753504","26753505","50105728","50105729","56463797","85230871","90341494"],"TG-GATEs":["140"],"Wikipedia":["Fenamic_acid"],"chEBI":["34756"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2448613","canonicalSmiles":"CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"RGSULKHNAKTFIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIMAVANSERIN TARTRATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nuplazid"],"synonyms":["ACP-103","Pimavanserin tartrate"],"crossReferences":{"DailyMed":["pimavanserin%20tartrate"]},"count":3,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0000249","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for parkinson's disease and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL254071","canonicalSmiles":"COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O","inchiKey":"QDDILOVMGWUNGD-UONOGXRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AUSTROBAILIGNAN 6","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Austrobailignan 6"],"crossReferences":{"PubChem":["26725241"],"drugbank":["DB14129"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255231","canonicalSmiles":"C#CCN[C@@H]1CCc2ccc(OC(=O)N(C)CC)cc21","inchiKey":"LHXOCOHMBFOVJS-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LADOSTIGIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ladostigil","TV-3326 FREE BASE"],"childChemblIds":["CHEMBL2448610","CHEMBL1788299"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL265948","canonicalSmiles":"Nc1nc2c(ncn2/C=C2/CC2(CO)CO)c(=O)[nH]1","inchiKey":"KMUNHOKTIVSFRA-KXFIGUGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILOCICLOVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclopropavir","Filociclovir","MBX-400","ZSM-162","ZSM-I 62","ZSM-I62"],"crossReferences":{"drugbank":["DB12438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270672","canonicalSmiles":"Cc1cc(=O)oc2cc(N)ccc12","inchiKey":"GLNDAGDHSLMOKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270672","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["3717444"],"drugbank":["DB08168"],"chEBI":["51771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL27759","canonicalSmiles":"Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1","inchiKey":"INVTYAOGFAGBOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENTINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Entinostat","MS-27-275","MS-275","MS-275-27","SNDX-275"],"crossReferences":{"PubChem":["137275820","29217590","529250"],"Wikipedia":["Entinostat"],"drugbank":["DB11841"]},"childChemblIds":["CHEMBL3093129"],"count":28,"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000068024","ENSG00000147099","ENSG00000100429","ENSG00000116478","ENSG00000163517","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0009878","EFO_0003086","EFO_0003869","EFO_1001901","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000657","MONDO_0021063","MONDO_0002087","MONDO_0003541","EFO_0000305","MONDO_0001187","EFO_1001951","MONDO_0002158","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0000198","EFO_0002618","EFO_0000616","EFO_1000616","MONDO_0008170","EFO_0000349","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000304","EFO_0006861","EFO_0005537","EFO_0000574","MONDO_0002367","MONDO_0024880","EFO_1000233"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL281795","canonicalSmiles":"CC(C)C[C@H](CC(=O)NO)C(=O)N[C@H]1Cc2cn(c3ccccc23)CCCCCCNC1=O","inchiKey":"GCBPAPVOMPJQHK-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL281795","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL287837","canonicalSmiles":"Clc1ccc2c(c1Cl)CNCC2","inchiKey":"WFPUBEDBBOGGIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SK&F-64139","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SK&F-64139","SK-64139"],"crossReferences":{"drugbank":["DB08550"],"chEBI":["160129"]},"childChemblIds":["CHEMBL541797"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295666","canonicalSmiles":"N[C@H](CCl)C(=O)O","inchiKey":"ASBJGPTTYPEMLP-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL295666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111003"],"drugbank":["DB01735"],"chEBI":["17092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298359","canonicalSmiles":"COC1=C(C)C(=O)C2=C(C1=O)[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N[C@H]3CN21","inchiKey":"HYFMSAFINFJTFH-NGSRAFSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOMYCIN A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mitomycin a","NSC-75986"],"crossReferences":{"chEBI":["85412"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3039528","canonicalSmiles":"CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C","inchiKey":"BYPMJBXPNZMNQD-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZICRONAPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LU-31-130","Lu 31-130","Zicronapine"],"crossReferences":{"drugbank":["DB12188"]},"childChemblIds":["CHEMBL3039534"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3099484","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN([11CH3])C2","inchiKey":"ASUTZQLVASHGKV-CNRJTYMMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3099484","maximumClinicalTrialPhase":0,"parentId":"CHEMBL659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137330","canonicalSmiles":"C[C@H]1CO[C@@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]","inchiKey":"AEZBWGMXBKPGFP-KIUAEZIZSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CABOTEGRAVIR SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2403238","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cabotegravir sodium","GSK-1265744B","GSK1265744B","S-265744B"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL316157","canonicalSmiles":"O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12","inchiKey":"CZTQZXZIADLWOZ-CRAIPNDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALORIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kefloridin","Loridine"],"synonyms":["40602","Cefaloridine","Cephaloridine"],"crossReferences":{"PubChem":["144204921"],"Wikipedia":["Cephaloridine"],"drugbank":["DB09008"],"chEBI":["3537"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3183968","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(CSc3nc(=O)c([O-])nn3C)CS[C@H]12)c1csc(N)n1.O.O.O.[Na+].[Na+]","inchiKey":"XMCDZRXQAGFWAK-PMCOHIMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTRIAXONE SODIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL161","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftriaxone","Rocephin"],"synonyms":["Ceftriaxone disodium salt","Ceftriaxone disodium salt hemiheptahydrate","Ceftriaxone sodium","Ceftriaxone sodium hydrate","Ceftriaxone sodium sesquaterhydrate","RO 13-9904","RO-13-9904"],"crossReferences":{"DailyMed":["ceftriaxone%20sodium"],"PubChem":["144204939","170465387"]},"count":8,"approvedIndications":["HP_0100806","EFO_1001388","EFO_0000584","EFO_0003103","EFO_0000544","DOID_7551","EFO_0004992"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 7 approved and 1 investigational indication."}
{"id":"CHEMBL31965","canonicalSmiles":"C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1","inchiKey":"OMZCMEYTWSXEPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1033","Canertinib"],"crossReferences":{"PubChem":["124894124","144206912","174006548","50100094"],"Wikipedia":["Canertinib"],"drugbank":["DB05424"],"chEBI":["61399"]},"childChemblIds":["CHEMBL545315"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0021117","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL323556","canonicalSmiles":"CC1CNCCN1S(=O)(=O)c1cccc2cnccc12","inchiKey":"BDVFVCGFMNCYPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323556","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124880257","124880258","26751761","56322739","855933","90341587"],"drugbank":["DB07996"],"chEBI":["43385"]},"childChemblIds":["CHEMBL540848","CHEMBL1256679"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3250775","canonicalSmiles":"O=S(=O)(O)O.[2H]C(C)(N)C([2H])([2H])c1ccccc1","inchiKey":"SOFQDLYSFOWTJX-RGDSUAAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250775","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329985","canonicalSmiles":"CC(C)(C)c1ccc(Sc2cccc3nc(N)nc(N)c23)cc1","inchiKey":"MNYDVPDMLAJJPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329985","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301675","canonicalSmiles":"C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC3=O)C(=O)N2","inchiKey":"KXGCNMMJRFDFNR-WDRJZQOASA-N","drugType":"Protein","blackBoxWarning":true,"name":"LINACLOTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Constella","Linzess"],"synonyms":["ASP-0456","ASP0456","Linaclotide","MD-1100"],"crossReferences":{"DailyMed":["linaclotide"],"drugbank":["DB08890"],"chEBI":["68551"]},"childChemblIds":["CHEMBL3301676"],"count":3,"approvedIndications":["EFO_0000555","HP_0002019"],"linkedTargets":{"rows":["ENSG00000070019"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0005406","HP_0012450","HP_0002019","EFO_1001951"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for constipation and irritable bowel syndrome and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3304486","canonicalSmiles":"CN(C)CC(C)(C)OC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"WJIZVQNUJVMJAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFEMERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"year":1986},"tradeNames":[],"synonyms":["Difemerine"],"childChemblIds":["CHEMBL3301670"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease. It was withdrawn in Germany  in 1986."}
{"id":"CHEMBL3391662","canonicalSmiles":"Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1","inchiKey":"UAUIUKWPKRJZJV-QPLHLKROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARITAPREVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABT-450","Paritaprevir"],"crossReferences":{"drugbank":["DB09297"]},"childChemblIds":["CHEMBL3781660"],"count":4,"approvedIndications":["EFO_0004220","EFO_0003047"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection and has 2 investigational indications."}
{"id":"CHEMBL3417258","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(CCl)O[C@@H](n2ccc(N)nc2=O)[C@H](F)[C@@H]1OC(=O)C(C)C","inchiKey":"MJVKYGMNSQJLIN-KYZVSKTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALS-008176","Lumicitabine"],"crossReferences":{"drugbank":["DB14808"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL344159","canonicalSmiles":"Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1","inchiKey":"GYHCTFXIZSNGJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLVAPTAN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jinarc","Jynarque","Samsca"],"synonyms":["OPC-41061","OPC-41061(TOLVAPTAN)","Tolvaptan"],"crossReferences":{"DailyMed":["tolvaptan"],"PubChem":["124894207","144206807"],"Wikipedia":["Tolvaptan"]},"count":13,"approvedIndications":["HP_0002902","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000126895"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0002094","EFO_1001771","EFO_0000373","EFO_0000319","EFO_0000313","EFO_1001496","EFO_0000311","EFO_0001422","HP_0002902","EFO_0003144","EFO_0003884","EFO_0004253","EFO_1000982"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for hyponatremia and cardiovascular disease and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL345248","canonicalSmiles":"BrC(Br)Br","inchiKey":"DIKBFYAXUHHXCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOFORM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromoform"],"crossReferences":{"PubChem":["144207387","17389702"],"Wikipedia":["Bromoform"],"drugbank":["DB03054"],"chEBI":["38682"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL351631","canonicalSmiles":"O=C([O-])c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1.[Na+]","inchiKey":"FOXZSJZEADRHAD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL351631","maximumClinicalTrialPhase":0,"parentId":"CHEMBL428880","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["554693"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545012","drugType":"Small molecule","blackBoxWarning":false,"name":"DSP-2230","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dsp-2230"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545299","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-698769","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-698769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545325","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-125844","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-125844","SAR125844","Sar-125844"],"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3651966","canonicalSmiles":"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1","inchiKey":"VRQXRVAKPDCRCI-ZNMIVQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3651966","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36994","canonicalSmiles":"COc1ccc(C(=O)N2CCCC2=O)cc1","inchiKey":"ZXNRTKGTQJPIJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampamet","Aniracetam","Draganon","Memodrin","RO 13-5057","Sarpul"],"crossReferences":{"PubChem":["104171112","11113324","144203637","170465854","26746909","50103913","855554","856168"],"Wikipedia":["Aniracetam"],"drugbank":["DB04599"],"chEBI":["47943"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707209","canonicalSmiles":"CCCC(C)(CCO[N+](=O)[O-])O[N+](=O)[O-]","inchiKey":"SNMKANWYFGWYCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPROPYLPROPANEDIOL DINITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylpropylpropanediol dinitrate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707256","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS ASPARTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous aspartate"],"crossReferences":{"DrugCentral":["4541"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707299","canonicalSmiles":"NC(CO)(CO)CO.O=C(O[Al](O)O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"GJJYZOBRHIMORS-GQOAHPRESA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLUTAMOL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707300","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloglutamol"],"crossReferences":{"DrugCentral":["4759"],"drugbank":["DB13650"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707307","canonicalSmiles":"CCOc1ccc2nc(SCCN3CCOCC3)[nH]c2c1","inchiKey":"WWNUCVSRRUDYPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FABOMOTIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fabomotizole"],"crossReferences":{"drugbank":["DB13623"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707396","drugType":"Small molecule","blackBoxWarning":false,"name":"EVT401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evt401"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833382","canonicalSmiles":"CCC[N+]12[C@H]3C[C@@]45c6ccccc6N(C)[C@H]4[C@@H]1C[C@@H]([C@H](CC)[C@H]2O)[C@H]3[C@H]5O","inchiKey":"UAUHEPXILIZYCU-GSPNQRMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAJMALIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Prajmaline"],"childChemblIds":["CHEMBL3833388"],"count":1,"approvedIndications":["EFO_0004269"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiac arrhythmia."}
{"id":"CHEMBL3833385","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2cnc(C4CC4)s2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C","inchiKey":"LTSZWQVAHDFPNW-PRMCSTHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUZASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8408","Ruzasvir"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL383824","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O","inchiKey":"KUFRQPKVAWMTJO-LMZWQJSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVESPIMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvespimycin","NSC-707545"],"crossReferences":{"Wikipedia":["17-Dimethylaminoethylamino-17-demethoxygeldanamycin"],"drugbank":["DB12442"],"chEBI":["65324"]},"childChemblIds":["CHEMBL2105630"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL395429","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"XNOPRXBHLZRZKH-DSZYJQQASA-N","drugType":"Protein","blackBoxWarning":true,"name":"OXYTOCIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orasthin","Oxytocin","Pitocin","Syntocinon","Syntometrine"],"synonyms":["Oxytocin","TTA-121"],"crossReferences":{"DailyMed":["oxytocin"],"PubChem":["50112429"],"chEBI":["7872"]},"childChemblIds":["CHEMBL3185709"],"count":43,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000180914"],"count":1},"linkedDiseases":{"rows":["Orphanet_282","EFO_0004566","EFO_0004777","EFO_0002610","MONDO_0002009","EFO_0008507","EFO_0003768","EFO_1001917","EFO_1000948","EFO_0009579","EFO_0010642","EFO_0003829","EFO_0002950","EFO_1001271","EFO_0004247","Orphanet_739","MONDO_0002050","EFO_0004714","EFO_1000911","EFO_0004616","EFO_1000096","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0003877","EFO_0004215","EFO_0005762","EFO_0003888","EFO_0003756","Orphanet_48652","HP_0012532","EFO_0004269","EFO_0003758","EFO_0001358","EFO_0010702","EFO_0010445","EFO_0001073","EFO_0003843","Orphanet_908","MP_0001914","EFO_0001072","MP_0001845","EFO_0003890","MONDO_0002491","GO_0007568","EFO_0000432","EFO_0000612","EFO_0005611","EFO_1001863","EFO_0003918","EFO_0005411","EFO_0000668"],"count":52},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for hemorrhage and has 42 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989523","canonicalSmiles":"N=C(N)NCc1cccc([123I])c1.N=C(N)NCc1cccc([123I])c1.O=S(=O)(O)O","inchiKey":"XNACDNPGABUBFR-FKNPGSCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE SULFATE I 123","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adreview"],"synonyms":["Iobenguane sulfate i 123","Iobenguane sulfate i-123","Iodobenzylguanidine sulfate i 123","Mibg-i-123"],"crossReferences":{"DailyMed":["iobenguane%20sulfate%20i-123"],"drugbank":["DB09546"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008."}
{"id":"CHEMBL3989568","canonicalSmiles":"CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.[Ca+2]","inchiKey":"KIPLYOUQVMMOHB-MXWBXKMOSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE CALCIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1517","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Terramycin"],"synonyms":["Oxytetracycline calcium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL3989821","canonicalSmiles":"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.Cl.O.O.O.O.O.[Cl-]","inchiKey":"WMIZITXEJNQAQK-GGDSLZADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBOCURARINE CHLORIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL339427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jexin","Tubarine","Tubocurarine chloride"],"synonyms":["Tubocurarine chloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL406291","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O","inchiKey":"QXZGBUJJYSLZLT-FDISYFBBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BRADYKININ","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRS-640","Bradykinin"],"crossReferences":{"PubChem":["50112435"],"Wikipedia":["Bradykinin"],"drugbank":["DB12126"],"chEBI":["3165"]},"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL406821","canonicalSmiles":"Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12","inchiKey":"AWDORCFLUJZUQS-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H-1152P","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H-1152P"],"crossReferences":{"drugbank":["DB07876"],"chEBI":["88220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416","canonicalSmiles":"COc1c2occc2cc2ccc(=O)oc12","inchiKey":"QXKHYNVANLEOEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOXSALEN","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["8-mop","Deltasoralen","Meladinine","Methoxsalen","Oxsoralen","Oxsoralen-ultra","Puvasoralen-8","Uvadex"],"synonyms":["8-methoxypsoralen","Methoxsalen","NSC-45923","SM-88 COMPONENT METHOXSALEN","Xanthotoxin"],"crossReferences":{"DailyMed":["methoxsalen"],"PubChem":["104171301","11112313","144203983","144208965","144213133","170465041","17389831","174006539","26752292","4255217","50105146","99459"],"Wikipedia":["Methoxsalen"],"drugbank":["DB00553"],"chEBI":["18358"]},"count":11,"approvedIndications":["EFO_0000676"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for psoriasis and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL428676","canonicalSmiles":"CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O","inchiKey":"UPALIKSFLSVKIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMONAFIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1413","Amonafide","NSC-308847"],"crossReferences":{"PubChem":["454647"],"Wikipedia":["Amonafide"],"drugbank":["DB05022"]},"childChemblIds":["CHEMBL1910266","CHEMBL538838","CHEMBL2104952"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297163","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"MUPARFOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muparfostat","PI-88"],"childChemblIds":["CHEMBL4297162"],"count":6,"linkedTargets":{"rows":["ENSG00000138685","ENSG00000113578","ENSG00000173083","ENSG00000112715"],"count":4},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0008903","EFO_0000182","EFO_0000389","EFO_0003060","MONDO_0008315"],"count":6},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297185","canonicalSmiles":"CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1","inchiKey":"BLIJXOOIHRSQRB-PXYINDEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAROLUTAMIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nubeqa"],"synonyms":["BAY 1841788","BAY-1841788","BAY1841788","Darolutamide","ODM-201","Odm-201"],"crossReferences":{"DailyMed":["darolutamide"],"drugbank":["DB12941"]},"count":6,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000196","MONDO_0007254","MONDO_0008315","EFO_0001663","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for neoplasm and has 5 investigational indications."}
{"id":"CHEMBL4297347","drugType":"Unknown","blackBoxWarning":false,"name":"DOTAMTATE PB-212","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300858","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alphamedix","Dotamtate pb-212"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297389","canonicalSmiles":"O=C1[C@H](C/C=C(\\CO)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1","inchiKey":"HEHHPZYUXSFAPV-SMOXZEHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYZETIMIBE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-25","Hs-25","Hyzetimibe"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297403","canonicalSmiles":"CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccc(N(CCCl)CCCl)cc1.Cl","inchiKey":"ZCMWSKHHXLCVHI-VROPFNGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELPHALAN FLUFENAMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4303060","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK 1535","J-1 HYDROCHLORIDE","J1 hydrochloride ","Melflufen","Melphalan flufenamide hydrochloride"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297440","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O","inchiKey":"FSXLOWIFSZNIMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-900607","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T 900607","T-900607","T900607"],"crossReferences":{"drugbank":["DB12068"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297454","canonicalSmiles":"CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1","inchiKey":"OEDSFMUSNZDJFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABBV-744","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-744","Abbv-744"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297559","drugType":"Unknown","blackBoxWarning":false,"name":"HILTONOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hiltonol","Poly-iclc"],"count":20,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL4297576","drugType":"Protein","blackBoxWarning":false,"name":"EFINOPEGDUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efinopegdutide","HM-12525A","HM12525A","JNJ-64565111","Jnj-64565111"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297627","canonicalSmiles":"C[C@@H]1CCc2ncc(F)cc2[C@H]2CCCN2c2ccn3ncc(c3n2)C(=O)N1","inchiKey":"OEBIHOVSAMBXIB-SJKOYZFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELITRECTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LOXO-195","Loxo-195","Selitrectinib"],"crossReferences":{"drugbank":["DB14896"]},"count":1,"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297757","drugType":"Unknown","blackBoxWarning":false,"name":"GDC-0077","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0077","GDC0077","Gdc-0077","Inavolisib"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297776","drugType":"Unknown","blackBoxWarning":false,"name":"LEFITOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lefitolimod","MGN-1703","TLR9 AGONIST MGN1703"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298118","drugType":"Unknown","blackBoxWarning":false,"name":"PREIMPLANTATION FACTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Preimplantation factor","Synthetic preimplantation factor"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL444633","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O","inchiKey":"ATEBXHFBFRCZMA-VXTBVIBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFABUTIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mycobutin","Rifabutin"],"synonyms":["Ansamycin","LM 427","LM-427","MYCOBUTIN","Rifabutin"],"crossReferences":{"DailyMed":["rifabutin"],"PubChem":["144204563","144207956"],"Wikipedia":["Rifabutin"],"drugbank":["DB00615"],"chEBI":["45367"]},"count":8,"approvedIndications":["EFO_0000764","EFO_0000180","Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL4592045","canonicalSmiles":"CCc1cc(F)c2nc(N3CCC(NC4CCOCC4)CC3)c(-c3nc(C)no3)c(C)c2c1","inchiKey":"CQOJHAJWCDJEAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BTRX-335140","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTRX-335140","Btrx-335140","CYM-53093"],"childChemblIds":["CHEMBL4455146"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594535","drugType":"Antibody","blackBoxWarning":false,"name":"SUGEMALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-1001","CS1001","Cs1001","Sugemalimab","WBP-315","WBP315"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594571","drugType":"Unknown","blackBoxWarning":false,"name":"LU AF-82422","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-82422","LU AF-82422","LU AF82422","Lu af-82422","Lu af82422"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460910","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](CN3CCCCC3)O2)c(=O)[nH]c1=O","inchiKey":"GMOUOGHZJCSNOZ-YNEHKIRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL463321","canonicalSmiles":"CCCCCC(=O)CC(=O)N[C@H]1CCOC1=O","inchiKey":"FXCMGCFNLNFLSH-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL463321","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08081"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL464982","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\CCCCC(=O)O","inchiKey":"VZCCETWTMQHEPK-QNEBEIHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMOLENIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efamast 40","Efamast 80","Epoc","Epogam","Epogam 40","Epogam 80","Epogam paed","Gam-o","Gammolin","Gamophase","Kentogam","Lin-gam","Unigam"],"synonyms":[".gamma.-linolenic acid","18:3(N-6)","Gamolenic acid","NDI 609"],"crossReferences":{"PubChem":["144205388","26754623","26754624","29216151","50110102","57260207"],"Wikipedia":["Gamma-Linolenic_acid"],"drugbank":["DB13854"],"chEBI":["28661"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL46778","canonicalSmiles":"O=CNC1CCCCC1","inchiKey":"SWGXDLRCJNEEGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Cyclohexyl-Formamide"],"crossReferences":{"drugbank":["DB03559"],"chEBI":["17945"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46817","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1","inchiKey":"FGGSNQOBRJVAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07562"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485747","canonicalSmiles":"OCCCc1ccc(O)c(O)c1","inchiKey":"DPTPQXXDBLPEOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYTYROSOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxytyrosol"],"crossReferences":{"PubChem":["24841446"],"Wikipedia":["Hydroxytyrosol"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL487253","canonicalSmiles":"Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21","inchiKey":"YTKUWDBFDASYHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAMUSTINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bendamustine"],"crossReferences":{"DailyMed":["bendamustine%20hydrochloride"],"PubChem":["144206324","170465340","174007431","50125886"],"Wikipedia":["Bendamustine"],"drugbank":["DB06769"]},"childChemblIds":["CHEMBL1201734"],"count":28,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cancer and neoplasm and has 26 investigational indications."}
{"id":"CHEMBL489","canonicalSmiles":"CC/C(=C(\\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1","inchiKey":"TXUZVZSFRXZGTL-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFIMOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tamogel"],"synonyms":["4-Hydroxytamoxifen","4-OHT","Afimoxifene"],"crossReferences":{"PubChem":["11532960","144208141","26757818","56422185"],"Wikipedia":["Afimoxifene"],"drugbank":["DB04468"],"chEBI":["44616"]},"count":2,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009","ENSG00000196482"],"count":3},"linkedDiseases":{"rows":["EFO_1001366","EFO_0000432"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL501174","canonicalSmiles":"CC(C)=CCC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(\\C)CCC=C(C)C","inchiKey":"OAIJSZIZWZSQBC-GYZMGTAESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYCOPENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-160D(III)","E160d","FEMA NO. 4110","INS NO.160D(III)","INS-160D(III)","Lycopene","NSC-407322"],"crossReferences":{"PubChem":["144205948","29218049"],"Wikipedia":["Lycopene"],"drugbank":["DB11231"],"chEBI":["15948"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL509","canonicalSmiles":"Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl","inchiKey":"SBDNJUWAMKYJOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MECLOFENAMIC ACID","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CI-583","CL-583","INF 4668","INF-4668","Meclodium","Meclofenamate","Meclofenamic acid","Meclomen","NSC-95309"],"crossReferences":{"DailyMed":["meclofenamate%20sodium"],"PubChem":["24424562","26751537","90341585"],"Wikipedia":["Meclofenamic_acid"],"drugbank":["DB00939"],"chEBI":["6710"]},"childChemblIds":["CHEMBL1562610","CHEMBL876"],"count":3,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":3},"linkedDiseases":{"rows":["HP_0002829","HP_0003326","EFO_0005755"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL518924","canonicalSmiles":"NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21","inchiKey":"WVLHHLRVNDMIAR-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVORIXAFOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMD-070","AMD-11070","AMD070","AMD11070","Amd 070","Amd070","Mavorixafor","X 4P-001","X4P-001"],"crossReferences":{"drugbank":["DB05501"]},"childChemblIds":["CHEMBL4203190"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL52440","canonicalSmiles":"COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3","inchiKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHORPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dextromethorphan","Dimetane-DX"],"crossReferences":{"DailyMed":["dextromethorphan%20hydrobromide"],"PubChem":["11111057","50100218"],"Wikipedia":["Dextromethorphan"],"drugbank":["DB00514"]},"childChemblIds":["CHEMBL1201461","CHEMBL3989946","CHEMBL3989940","CHEMBL1201004","CHEMBL1256818"],"count":30,"approvedIndications":["HP_0012735"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000147955"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0005687","EFO_0007486","Orphanet_232","HP_0012735","MONDO_0002009","EFO_0000555","EFO_0000249","EFO_1001919","Orphanet_778","Orphanet_68380","EFO_1000783","HP_0100543","EFO_0009430","EFO_0000289","MONDO_0002050","EFO_0000544","EFO_0003100","EFO_0000676","EFO_0000253","EFO_0002460","EFO_0009321","EFO_0000692","EFO_0002617","EFO_0005762","EFO_0000616","EFO_0002508","EFO_0003821","HP_0000093","EFO_0009692","EFO_0003758","EFO_0003929","EFO_0000384","EFO_0003843","MONDO_0008315","EFO_0001663","EFO_0007214","EFO_0003885","EFO_0000270","EFO_0000764","EFO_0005611","EFO_0001360","EFO_0003785","EFO_0001062"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cough and has 29 investigational indications."}
{"id":"CHEMBL549","canonicalSmiles":"CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WSEQXVZVJXJVFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CITALOPRAM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Celexa","Citalopram"],"crossReferences":{"DailyMed":["citalopram%20hydrobromide"],"PubChem":["174007166","50104852","90340852"],"Wikipedia":["Citalopram"],"drugbank":["DB00215"],"chEBI":["77397"]},"childChemblIds":["CHEMBL1628605","CHEMBL1200781"],"count":18,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["Orphanet_282","EFO_0003756","EFO_0002610","EFO_0004262","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0002508","EFO_0003758","HP_0031217","Orphanet_95","EFO_0003829","HP_0000713","MONDO_0002046","EFO_0003948","EFO_0000289","MONDO_0002050","EFO_0000712","EFO_0003761","EFO_0005611","HP_0100749","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005672"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for depressive disorder and unipolar depression and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL571948","canonicalSmiles":"C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1","inchiKey":"JTVBXQAYBIJXRP-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Y-39983","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Y-39983"],"childChemblIds":["CHEMBL3794409"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL612","canonicalSmiles":"C[C@H](N)Cc1ccccc1","inchiKey":"KWTSXDURSIMDCE-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEXTROAMPHETAMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexedrine","Dextrostat"],"synonyms":["Dexamfetamine","Dexampex","Dexamphetamine","Dexedrine","Dextroamphetamine","Dextroamphetamine resin complex","Dextrostat","Ferndex","NSC-73713","d-Amphetamine"],"crossReferences":{"DailyMed":["dextroamphetamine%20saccharate","dextroamphetamine%20sulfate"],"PubChem":["50113060"],"Wikipedia":["Dextroamphetamine"],"drugbank":["DB01576"],"chEBI":["4469"]},"childChemblIds":["CHEMBL1200782","CHEMBL287386","CHEMBL2106669","CHEMBL3544971","CHEMBL3989844"],"count":9,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003885","EFO_0002610","MONDO_0002050","EFO_0000289","EFO_0000712","EFO_0000326","EFO_0005611","EFO_0004701","EFO_0000692","EFO_0000614"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for attention deficit hyperactivity disorder and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL6367","canonicalSmiles":"CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1","inchiKey":"OQAHHWOPVDDWHD-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GPI-1046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GPI-1046"],"crossReferences":{"drugbank":["DB01951"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL637","canonicalSmiles":"COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1","inchiKey":"PNVNVHUZROJLTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VENLAFAXINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alventa xl","Amphero xl","Bonilux xl","Depefex xl","Efexor","Efexor xl","Foraven xl","Mentaven xl","Politid xl","Ranfaxine xl","Rodomel xl","Sunveniz xl","Tardcaps xl","Tifaxin xl","Tonpular xl","Trixat xl","Vaxalin xl","Venaxx xl","Venlablue xl","Venladex xl","Venlalic xl","Venlaneo xl","Vensir xl","Vexarin xl","Viepax","Viepax xl","Winfex xl"],"synonyms":["Effexor","Venlafaxine"],"crossReferences":{"DailyMed":["venlafaxine%20hydrochloride"],"PubChem":["144204978","170465123","174007175","26748923","90341232"],"Wikipedia":["Venlafaxine"],"drugbank":["DB00285"],"chEBI":["9943"]},"childChemblIds":["CHEMBL1201066","CHEMBL3133301"],"count":3,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0006862","EFO_0002610","EFO_0004262","EFO_0005687","MONDO_0002009","HP_0000726","EFO_0000249","EFO_1001919","MONDO_0007254","EFO_1001917","HP_0031217","EFO_0000289","MONDO_0002050","EFO_0000673","EFO_0003761","EFO_0009854","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005762","EFO_0003821","EFO_0002508","EFO_0001358","MONDO_0008315","EFO_1001892","HP_0030833","MONDO_0043510","EFO_0003918"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for depressive disorder and unipolar depression and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL681","canonicalSmiles":"CCOC(=O)c1cncn1[C@H](C)c1ccccc1","inchiKey":"NPUKDXXFDDZOKR-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOMIDATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amidate","Etomidate"],"synonyms":["Etomidate"],"crossReferences":{"DailyMed":["etomidate"],"PubChem":["11114097"],"drugbank":["DB00292"],"chEBI":["4910"]},"count":3,"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000182256","ENSG00000102287","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0009686","MONDO_0002050","EFO_0005323","EFO_1001905","EFO_0001645","EFO_0000712","HP_0001336","EFO_0009267","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL780","canonicalSmiles":"O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O","inchiKey":"QPCDCPDFJACHGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETIC ACID","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DTP-A","DTPA","NSC-7340","Pentetate","Pentetic acid"],"crossReferences":{"DailyMed":["pentetate%20calcium%20trisodium","pentetate%20zinc%20trisodium"],"PubChem":["104171146","11111089","11111090","144203682","170465150","26753562","50106210","85231007","90341568"],"Wikipedia":["Pentetic_acid"],"drugbank":["DB14007"],"chEBI":["35739"]},"childChemblIds":["CHEMBL1200424","CHEMBL1200945"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL83626","canonicalSmiles":"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1","inchiKey":"RKSMVPNZHBRNNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINOBUCOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGI-1067","Succinobucol"],"crossReferences":{"drugbank":["DB05399"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL87543","canonicalSmiles":"CC(C)N1CCC(N(C(=O)Cc2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"XHOJAWVAWFHGHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORCAINIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lorcainide"],"crossReferences":{"Wikipedia":["Lorcainide"],"drugbank":["DB13653"]},"childChemblIds":["CHEMBL3085477"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL914","canonicalSmiles":"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"RWTNPBWLLIMQHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEXOFENADINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Allegra","Fexofenadine"],"crossReferences":{"DailyMed":["fexofenadine%20hydrochloride"],"PubChem":["50105687","90341422"],"Wikipedia":["Fexofenadine"],"drugbank":["DB00950"],"chEBI":["5050"]},"childChemblIds":["CHEMBL1200618"],"count":8,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003948","EFO_0008521","EFO_0005531","HP_0000989","EFO_0000270","EFO_0000401","EFO_0009373","EFO_0000274","EFO_1001417","EFO_0003060","EFO_0003956","EFO_0003785"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for allergy and has 7 investigational indications."}
{"id":"CHEMBL931","canonicalSmiles":"FC(F)(F)C(Cl)Br","inchiKey":"BCQZXOMGPXTTIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOTHANE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluothane","Halothane","Rhidialothan"],"synonyms":["Halothane"],"crossReferences":{"PubChem":["144204584","144208048","170464645","17388981"],"Wikipedia":["Halothane"],"drugbank":["DB01159"],"chEBI":["5615"]},"childChemblIds":["CHEMBL3250431"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958."}
{"id":"CHEMBL94061","canonicalSmiles":"CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1","inchiKey":"ZCIXBBSRVLSRJQ-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL94061","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9967","canonicalSmiles":"CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1","inchiKey":"RMHMFHUVIITRHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRENZEPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gastri p","Gastrozepin"],"synonyms":["Pirenzepine"],"crossReferences":{"PubChem":["104171218","11111661","11111662","11113363","144203790","170465793","26751604","90341394"],"Wikipedia":["Pirenzepine"],"drugbank":["DB00670"],"chEBI":["8247"]},"childChemblIds":["CHEMBL1257024","CHEMBL1531864"],"count":2,"approvedIndications":["EFO_0003948","HP_0004398"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["HP_0004398","EFO_0003948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastroesophageal reflux disease and peptic ulcer."}
